March 27, 2026

Industry Insights: Genomic Testing for Early-Stage Breast Cancer

William Audeh, Chief Medical Officer at Agendia, discusses recent data supporting genomic testing results in guiding clinical decision-making

The Pathologist

March 26, 2026

Obesity’s Cancer Role Underestimated

A proposed framework highlights potential sources of bias in current estimates

Conexiant

March 26, 2026

Q&A: What are your ethical obligations if another dentist dies before completing treatment?

A recent news report described financial challenges faced by patients who had prepaid for treatment before their dentist unexpectedly died.

ADA News

March 26, 2026

Limits of Negative Infection Studies in AD

Perspective argues that study design and measurement challenges may obscure potential links between infection and disease

Conexiant

March 25, 2026

Value-based Healthcare: How Do We Get There?

Experts discuss ways to achieve a new model of proactive, population-level healthcare

The Pathologist

March 24, 2026

Organized Dentistry Coalition urges CMS to not prohibit adult dental coverage

ODC urged CMS to not prohibit adult dental coverage as an essential health benefit in the proposed Notice of Benefit and Payment Parameters.

ADA News

March 24, 2026

In Celebration of a Decades-Long Journey of Discovery and Innovation

On October 1, 2025, Benjamin L. Ebert, MD, PhD, celebrated the 1-year anniversary of being named President and Chief Executive Officer (CEO) of Dana-Farber Cancer Institute in Boston. He also holds th...

The ASCO Post

March 24, 2026

Forgotten Lessons From South Africa

On March 10, 2000, it was a cold Friday morning in Washington, DC. As usual, we the oncology fellows and faculty crowded into a conference room at the NIH Clinical Center in Building 10 for our weekly...

The ASCO Post

March 24, 2026

Reducing the Impact of Climate-Induced Events on Patients and Oncology Staff

Although 2023 made headlines as the hottest year in human history,1 drawing the world closer to breaching the goals outlined in the Paris Agreement to substantially reduce global greenhouse gas emissi...

The ASCO Post

March 24, 2026

GLP-1 Eye Effects Raise Questions

Authors describe both potential retinal benefits and possible rare optic nerve risks, while emphasizing that long-term ocular safety data remain limited as use expands.

Conexiant